- About us
- Our people
- Portfolio
- Sustainability
- News and Insights
- Investors
- Contact
To unlock the potential from truly innovative science to transform patients’ lives
We create, build and scale companies around exceptional science to create a diversified portfolio of 20-25 globally leading healthcare businesses
Syncona domain expertise
Our deep expertise in four key modalities enables the rapid translation of scientific research into companies with the potential to be global leaders and the development of a diversified portfolio of 20-25 companies
Making a positive contribution
We are committed to managing our business in a sustainable way, investing responsibly, and supporting our portfolio companies in making positive contributions to society by developing treatments that will make a difference to the lives of patients and their families.


Annual Report and Accounts 2022
Our Annual Report and Accounts 2022 provides an overview of our most recent financial year, as we look to deliver on behalf of our stakeholders.
An expert multi-disciplinary team, attracting world-class talent
We are differentiated by our people, who identify innovative technology and take a commercial approach to building businesses capable of delivering transformational treatments to patients.

Leadership key facts*
Members of the investment team
Years of life science and investment expertise
Investment team with PhDs or M.D.s
*All as of 31 December 2022